Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays
2022 · Alzheimer s & Dementia · 209 citations
https://doi.org/10.1002/alz.12841
A
Albert Puig‐Pijoan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
1.1K
Citations
16
h-index
24
i10-index
Albert Puig‐Pijoan is an academic researcher from Universitat Autònoma de Barcelona. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Neurological Disease Mechanisms and Treatments. The author has an h-index of 16, co-authored 56 publications.
ORCID: 0000-0002-9848-3711Papers by this author
worksPlasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform
2025 · Nature Medicine · 97 citations
https://doi.org/10.1038/s41591-025-03622-w
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
2024 · Nature Communications · 71 citations
https://doi.org/10.1038/s41467-024-47286-5
A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups
2024 · Alzheimer s & Dementia · 26 citations
https://doi.org/10.1002/alz.13676
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno‐Sandwich Assay
2025 · Alzheimer s & Dementia · 14 citations
https://doi.org/10.1002/alz.14621
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
2023 · Alzheimer s Research & Therapy · 12 citations
https://doi.org/10.1186/s13195-023-01201-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat